Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?
about
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged SwordThe Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureInnate immunity is sufficient for the clearance ofChlamydia trachomatisfrom the female mouse genital tractCCL5 regulation of mucosal chlamydial immunity and infection.Is cardiovascular disease preventable by vaccination?Pathogenesis of Chlamydia induced pelvic inflammatory disease.Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexesMouse strain-dependent chemokine regulation of the genital tract T helper cell type 1 immune response.Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective.Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Immune response to Chlamydophila abortus POMP91B protein in the context of different Pathogen Associated Molecular Patterns (PAMP); role of antigen in the orientation of immune response.Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.Chlamydia trachomatis-specific human CD8+ T cells show two patterns of antigen recognition.Prevention of Chlamydia-induced infertility by inhibition of local caspase activity.CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract.Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatisProtection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.Chlamydia muridarum infection-induced destruction of male germ cells and sertoli cells is partially prevented by Chlamydia major outer membrane protein-specific immune CD4 cells.Chlamydia muridarum major outer membrane protein-specific antibodies inhibit in vitro infection but enhance pathology in vivo.Fc receptor regulation of protective immunity against Chlamydia trachomatis.Distinct function of Th1 and Th2 type delayed type hypersensitivity: protective and pathological reactions to chlamydial infection.Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells.T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.Protective DNA immunization against Chlamydia pneumoniae.IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection.Chlamydia pneumoniae-specific cell-mediated and humoral immunity in healthy people.Genitourinary chlamydial infection: a reappraisal and hypothesis.
P2860
Q26851537-6A233CDE-6349-4D3D-9B74-8F0F23D819E7Q26864344-41A04534-E044-4E35-A326-5163E0975751Q29032025-DF080C6B-D19A-43D7-ACED-E00D52A30320Q33359789-9BE7911F-306A-45CF-837F-28E0AD5FF6ADQ33603398-7B9EF81C-CBB4-4792-AFD7-828728E74004Q33711646-AC5CB3D5-BB47-435D-962D-DA714FE99687Q34003020-47B8DBF4-A88E-4303-A1D8-EDE27274A7A9Q34003385-A2589318-032E-48EE-B030-73F12570B259Q34005217-E7CF25DE-7BCC-45AA-8F63-FDA54F3775CDQ34009652-F81E7202-B6B7-46EA-9E55-5B717CC38427Q34119773-7B20964D-CE48-41C1-AB76-970733677712Q34146342-B866F957-175A-4AA1-A7FA-CD32268934E1Q34708547-CB99557B-6DB3-4101-81D3-2079C4220D93Q35458412-393EC84D-96DE-4798-BBC7-FE7782D0C920Q35947252-BE2C9CF7-D592-4D5D-8E86-B71FD3101B24Q36444692-C5A61982-0CB5-48B2-A05E-B8B8C2D57ED1Q36641653-81C5BDA8-6FD7-4593-AD42-ADD817F2A38EQ36950621-E1E0B5BB-1FFB-4932-A857-A2D9CC5023F1Q37419766-3E8C568B-44C7-43C9-AAD5-59F337040F76Q37835358-20D2BAA2-D2D9-4AA9-AD20-BC9189095832Q37842770-42A2C566-7190-4196-9200-1C29BC5306DEQ37852729-E5C5CCC8-D826-4F7C-AD92-C2204C4EDB48Q37872443-B9262B67-FF1C-4BD9-A08B-8968F29A38B6Q37874260-A5B52B89-1B3F-4996-8A5F-2DC21888A80FQ37874602-7FD47DC8-3811-43BD-A913-BC75F6872E56Q37875919-8E88B590-FCFC-46EE-9146-72FF4454585EQ37876806-D386D153-5DDE-4A07-BE0A-6DA6169ADFADQ37877438-E82FCF65-E0E4-4BF9-98B0-51735F4DDD3FQ37880847-E0540AAB-C4E7-49CE-98FB-4D1654AD92FEQ43427569-0FD2908A-F24F-4FE0-BE16-F29B1D22E5F0
P2860
Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Studies in knockout mice revea ...... amma: is this true for humans?
@en
Studies in knockout mice revea ...... amma: is this true for humans?
@nl
type
label
Studies in knockout mice revea ...... amma: is this true for humans?
@en
Studies in knockout mice revea ...... amma: is this true for humans?
@nl
prefLabel
Studies in knockout mice revea ...... amma: is this true for humans?
@en
Studies in knockout mice revea ...... amma: is this true for humans?
@nl
P2093
P1476
Studies in knockout mice revea ...... amma: is this true for humans?
@en
P2093
P304
P356
10.1046/J.1365-3083.1997.D01-167.X
P577
1997-12-01T00:00:00Z